These CEDIA assays use a recombinant DNA technology to produce a unique homogeneous enzyme immunoassay system. Our CEDI assays are recognized worldwide for their ease-of-use, performance and lot-to-lot consistency. These new test kits can be used on a variety of clinical chemistry analyzer. Complementing these new assays, is a new multiconstituent immunosuppressant control. This liquid, whole blood control can be used with CEDIA Cyclosporine PLUS and Tacrolimus.